David J. Portman, a 10% owner of LeonaBio, Inc. (LONA), executed a significant purchase of the company's stock on October 26, 2026. Portman acquired 3,149,470 shares at a price of $3,149.47 per share, representing a total investment of approximately $9.92 billion.
This substantial acquisition by a major insider is often interpreted as a strong vote of confidence in LeonaBio's future performance and prospects. Such large-scale insider buying can signal the belief that the company's stock is undervalued or poised for significant growth.
The transaction adds to recent insider activity, with Portman's purchase being the most notable in terms of volume and value. Investors often closely monitor these filings for indications of internal sentiment regarding a company's trajectory.